In this study, we combine the spatial resolution advantage provided by MRI contrast imaging with a humanized targeted anti-MUC16 antibody to detect MUC16-expressing lesions of pancreatic cancer in mouse models. Here, MUC16 is linked to pancreatic neoplasm.